Shinobi Therapeutics
Silent. Precise. Potent.
San Diego, United States · Founded 2015 · $119.0M raised
- Headquarters
- San Diego, California
- Employees
- 11–50
- Founded
- 2015
- Business Model
- B2B
- Website
- shinobitx.com
- Total Funding
- $119.0M
- Last Round
- $9.0M Extension RoundAug 2024
- Rounds
- 3
About
Shinobi Therapeutics is a Japan-US biotechnology company developing immune-evasive iPSC-derived cell therapies for cancer and autoimmune diseases. Its proprietary Katana platform engineers hypoimmune iPS cells that evade both innate and antibody-mediated immune rejection, enabling off-the-shelf allogeneic therapies without the need for immunosuppression. Rooted in research from Kyoto University and UCSF, Shinobi launched in 2023 with a $51M Series A.
Summary
Shinobi Therapeutics is a Biotech company based in San Diego, United States, founded in 2015. It has raised $119.0M in total across 3 rounds, most recently a $9.0M Extension Round round in Aug 2024. Investors include Yosemite, Mitsubishi UFJ Financial and Japanese Agency for Medical Research and Development (AMED).
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Aug 2024
Sign up to see all 3 rounds
Series A through Grant — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Clinical-stage biotechnology company developing T-cell engager therapeutics for autoimmune and in...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/shinobi-therapeutics"><img src="https://indexed.vc/api/badge/company/shinobi-therapeutics" alt="Shinobi Therapeutics on Indexed.vc" width="260" height="76" /></a>